Cure 4 CF

Developer: The Cystic Fibrosis

Category: Lifestyle

Add App to Comparison

1K installs

Ratings not yet available

74 monthly active users

Revenue not available

Install Trends

Weekly +20

Trending

Monthly +96

Trending

Cure 4 CF Summary

Cure 4 CF is a mobile Android app in Lifestyle by The Cystic Fibrosis Foundation. Released in Dec 2024 (1 year ago). It has about 1K+ installs Based on AppGoblin estimates, it reaches roughly 74 monthly active users . Store metadata: updated Aug 20, 2025.

Recent activity: 20 installs this week (96 over 4 weeks) showing strong growth View trends →

Store info: Last updated on Google Play on Aug 20, 2025 .

SDKs, Trackers & Permissions

App not yet scanned for SDKs.

App Details

Store ID: com.nuclavis.cff

First Released: 2024-12-21

Store Last Updated: 2025-08-20

In-App Purchases: No

Ads: No

Website: nuclavis.com

App Store

Crawl Status: Success

AppGoblin First Crawled: 2025-04-06

AppGoblin Last Crawled: 2026-05-11

Ads & App-Ads.txt

App does not have ads.

AppGoblin SDK Scans

App not yet analyzed for SDKs.

The download and scan process is automated but can require manual troubleshooting. Feel free to reach out if your request does not complete in 24hrs or if you have any questions.

0★

Ratings: 0

5★

4★

3★

2★

1★

Screenshots

App Description

Take fundraising for Cystic Fibrosis Foundation anywhere with the Cure 4 CF app!

Take your fundraising for Cystic Fibrosis Foundation anywhere you are with the Cure 4 CF mobile app!

Fundraising has never been made easier with this app; you can:
Track your fundraising progress
Update your fundraising page with a personalized story.
Sending messages is made easier using the contacts stored on your device.
Share to Facebook and LinkedIn
Manage your team page, track team progress, and communicate with team members if you're a team captain.
And much more!

The Cure 4 CF mobile app is part of the Cystic Fibrosis Foundation and is only available to current participants. If you still need to register, please register.